Pay in 4 interest-free payments of $6.22 Learn more
Ships within 48 hours · Estimated delivery Aug 6 - Aug 11
Retatrutide Status Retatrutide remains in Phase 3 clinical trials with FDA approval projected for late 2026 to early 2027
Cell viability was determined via MTS assay at this stage for inflammatory marker normalization
Diabetes Care 34(Supplement_2):S279-84 Gerstein HC, Colhoun HM, Dagenais GR, Diaz R, Lakshmanan M, Pais P et al (2019) Dulaglutide and cardiovascular outcomes in type 2 diabetes (REWIND): a double-blind, randomised placebo-controlled trial
I didn't do my face to look like a supermodel
On post-injection days no effects were found in females (Figure 3C)
US$ 21.43
US$ 25.26
US$ 22.88
US$ 29.27
US$ 29.62
US$ 29.44
